|
1
|
Guariguata L, Whiting DR, Hambleton I,
Beagley J, Linnenkamp U and Shaw JE: Global estimates of diabetes
prevalence for 2013 and projections for 2035. Diabetes Res Clin
Pract. 103:137–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Doran AC, Meller N and McNamara CA: Role
of smooth muscle cells in the initiation and early progression of
atherosclerosis. Arterioscler Thromb Vasc Biol. 28:812–819. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang CN, Chan KC, Lin WT, Su SL and Peng
CH: Hibiscus sabdariffa inhibits vascular smooth muscle cell
proliferation and migration induced by high glucose-a mechanism
involves connective tissue growth factor signals. J Agric Food
Chem. 57:3073–3079. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hall JL, Matter CM, Wang X and Gibbons GH:
Hyperglycemia inhibits vascular smooth muscle cell apoptosis
through a protein kinase C-dependent pathway. Circ Res. 87:574–580.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li H, Télémaque S, Miller RE and Marsh JD:
High glucose inhibits apoptosis induced by serum deprivation in
vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl.
Diabetes. 54:540–545. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Balasubramanyam M, Sampathkumar R and
Mohan V: Is insulin signaling molecules misguided in diabetes for
ubiquitin-proteasome mediated degradation? Mol Cell Biochem.
275:117–125. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Patterson C: Search and destroy: The role
of protein quality control in maintaining cardiac function. J Mol
Cell Cardio. 40:438–441. 2006. View Article : Google Scholar
|
|
8
|
Drews O and Taegtmeyer H: Targeting the
ubiquitin-proteasome system in heart disease: The basis for new
therapeutic strategies. Antioxid Redox Signal. 21:2322–2343. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meiners S, Laule M, Rother W, Guenther C,
Prauka I, Muschick P, Baumann G, Kloetzel PM and Stangl K:
Ubiquitin-proteasome pathway as a new target for the prevention of
restenosis. Circulation. 105:483–489. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Herrmann J, Ciechanover A, Lerman LO and
Lerman A: The ubiquitin-proteasome system in cardiovascular
diseases-a hypothesis extended. Cardiovasc Res. 61:11–21. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Seki N, Hattori A, Sugano S, Muramatsu M
and Saito T: cDNA cloning, expression profile, and genomic
structure of human and mouse RNF10/Rnf 10 genes, encoding a novel
RING finger protein. J Hum Genet. 45:38–42. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saurin AJ, Borden KL, Boddy MN and
Freemont PS: Does this have a familiar RING? Trends Biochem Sci.
21:208–214. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang K, Nair AK, Muller YL, Piaggi P,
Bian L, Del Rosario M, Knowler WC, Kobes S, Hanson RL, Bogardus C
and Baier LJ: Whole exome sequencing identifies variation in CYB5A
and RNF10 associated with adiposity and type 2 diabetes. Obesity
(Silver Spring). 22:984–988. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu G, Chen J, Li S, Pu P, Huang W, Zhao Y,
Wang R and Lei H: RING finger protein 10 prevents neointimal
hyperplasia by promoting apoptosis in vitro and in vivo. Life Sci.
208:325–332. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang J, Fan Z, Yang J, Ding J, Yang C and
Chen L: MicroRNA-24 attenuates neointimal hyperplasia in the
diabetic rat carotid artery injury model by inhibiting Wnt4
signaling pathway. Int J Mol Sci. 17(pii): E7652016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuan X, Zhang T, Yao F, Liao Y, Liu F, Ren
Z, Han L, Diao L, Li Y, Zhou B, et al: THO complex-dependent
posttranscriptional control contributes to vascular smooth muscle
cell fate decision. Circ Res. 123:538–549. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Xia G, Zhang Y, Liu J, Liu X, Li
W, Lv Y, Wei S, Liu J and Quan J: Palmitate induces VSMC apoptosis
via toll like receptor (TLR)4/ROS/p53 pathway. Atherosclerosis.
263:74–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang D, Sun C, Zhang J, Lin S, Zhao L,
Wang L, Lin R, Lv J and Xin S: Proliferation of vascular smooth
muscle cells under inflammation is regulated by NF-κB
p65/microRNA-17/RB pathway activation. Int J Mol Med. 41:43–50.
2018.PubMed/NCBI
|
|
19
|
Pan CH, Li PC, Chien YC, Yeh WT, Liaw CC,
Sheu MJ and Wu CH: Suppressive activities and mechanisms of ugonin
J on vascular smooth muscle cells and balloon angioplasty-induced
neointimal hyperplasia. Phytother Res. 32:312–320. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lecker SH, Solomon V, Price SR, Kwon YT,
Mitch WE and Goldberg AL: Ubiquitin conjugation by the N-end rule
pathway and mRNAs for its components increase in muscles of
diabetic rats. J Clin Invest. 104:1411–1420. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin J, Friesen MT, Bocangel P, Cheung D,
Rawszer K and Wigle JT: Characterization of mesenchyme homeobox 2
(MEOX2) transcription factor binding to RING finger protein 10. Mol
Cell Biochem. 275:75–84. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Paolisso G, Rizzo MR, Barbieri M, Manzella
D, Ragno E and Maugeri D: Cardiovascular risk in type 2 diabetics
and pharmacological regulation of mealtime glucose excursions.
Diabetes Metab. 29:335–340. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Navarro-González Juan F and Mora-Fernández
C: The role of inflammatory cytokines in diabetic nephropathy. J Am
Soc Nephrol. 19:433–442. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Winkler G, Salamon F, Harmos G, Salamon D,
Speer G, Szekers O, Hajós P, Kovács M, Simon K and Cseh K: Elevated
serum tumor necrosis factor-alpha concentrations and bioactivity in
type 2 diabetics and patients with android type obesity. Diabetes
Res Clin Pract. 42:169–174. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bayón Y, Alonso A, Hernández M, Nieto ML
and Sánchez Crespo M: Mechanisms of cell signaling in
immune-mediated inflammation. Cytokines Cell Mol Ther. 4:275–286.
1998.PubMed/NCBI
|
|
26
|
Brownlee M: The pathobiology of diabetic
complications: A unifying mechanism. Diabetes. 54:1615–1625. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sherr CJ and Roberts JM: CDK inhibitors:
Positive and negative regulators of G1-phase progression. Genes
Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sylvester AM, Chen D, Krasinski K and
Andrés V: Role of c-fos and E2F in the induction of cyclin A
transcription and vascular smooth muscle cell proliferation. J Clin
Invest. 101:940–948. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu Z and Hunter T: Ubiquitylation and
proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2)
CDK inhibitors. Cell Cycle. 9:2342–2352. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Korsmeyer SJ: BCL-2 gene family and the
regulation of programmed cell death. Cancer Res. 59 (Suppl
7):S1693–S1700. 1999.
|
